We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
69 hedge funds and large institutions have $67.6M invested in Puma Biotechnology in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
404% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $201K
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
1% more funds holding
Funds holding: 68 → 69 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.79% less ownership
Funds ownership: 56.9% → 54.1% (-2.8%)
13% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 23
28% less capital invested
Capital invested by funds: $93.8M → $67.6M (-$26.2M)
Holders
69
Holders Change
+1
Holders Change %
+1.47%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
20
Reduced
23
Closed
5
Calls
$1.01M
Puts
$201K
Net Calls
+$813K
Net Calls Change
-$364K
Top Buyers
| 1 |
Millennium Management
New York
|
+$944K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$562K |
| 3 |
Citigroup
New York
|
+$340K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$168K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.2K |
